Shock Trial: Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock.

• Status: Completed
• Trial end date: 2005-12-01
• Target enrollment: 0
• Participant gender: All

Summary

To test if early revascularization, primarily with angioplasty (PTCA) or bypass surgery (CABG), reduced all-cause in-hospital mortality from cardiogenic shock compared to conventional treatment, including thrombolysis.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: HealthCore-NERI; New England Research Institutes
• Collaborator: National Heart, Lung, and Blood Institute (NHLBI)
• Treatments: Fibrinolytic Agents

Criteria

Men and women with myocardial infarction and cardiogenic shock.